Engineering glucose-responsive insulin

Yi Zeng,Jinqiang Wang,Zhongze Gu,Zhen Gu
DOI: https://doi.org/10.1016/j.medidd.2019.100010
2019-01-01
Medicine in Drug Discovery
Abstract:People with type 1 or advanced type 2 diabetes are highly dependent on insulin. However, insulin cannot match its function to daily varying blood glucose levels, putting people with diabetes at risk of hypoglycemia. Glucose-responsive insulin is capable of improving blood glucose manipulation and elevating the life quality of people with diabetes. Therefore, enormous endeavors have been devoted to developing glucose-responsive insulin formulations, including glucose-responsive insulin delivery systems and glucose-responsive insulin analogs. In this review, we focus on glucose-responsive insulin analogs, especially three representatives, including phenylboronic acid-mediated, glucose transporter-mediated and lectin-mediated glucose-responsive insulin analogs. Based on the published studies, the opportunities and challenges to engineering glucose-responsive insulin analogs are also discussed.
What problem does this paper attempt to address?